CIAN HEALTHCARE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.5 INR | +1.62% |
|
+0.70% | +43.53% |
| 2023 | Cian Healthcare to Supply 13 Pharmaceutical Products for HLL Lifecare | MT |
| 2023 | Cian Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2023 | CI |
Valuation
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Capitalization 1 | 350.4 | 262.8 | 476.2 | 699.9 |
| Enterprise Value (EV) 1 | 1,017 | 946.9 | 1,093 | 1,295 |
| P/E ratio | -9.25 x | 563 x | -8.21 x | 34.6 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 0.61 x | 0.36 x | 0.61 x | 1.02 x |
| EV / Revenue | 1.77 x | 1.28 x | 1.4 x | 1.88 x |
| EV / EBITDA | 13.5 x | 7.76 x | 24 x | 9.89 x |
| EV / FCF | -2.96 x | -23.8 x | -8.24 x | -181 x |
| FCF Yield | -33.8% | -4.21% | -12.1% | -0.55% |
| Price to Book | 0.6 x | 0.45 x | 0.86 x | 1.22 x |
| Nbr of stocks (in thousands) | 23,361 | 23,361 | 24,996 | 24,996 |
| Reference price 2 | 15.00 | 11.25 | 19.05 | 28.00 |
| Announcement Date | 20-09-06 | 21-09-06 | 22-09-05 | 23-09-05 |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 595.9 | 634 | 573.3 | 739.4 | 780.7 | 687 |
| EBITDA 1 | 122.2 | 91.73 | 75.19 | 122 | 45.64 | 131 |
| EBIT 1 | 106.7 | 67.83 | 30.7 | 87.46 | 2.891 | 76.66 |
| Operating Margin | 17.91% | 10.7% | 5.35% | 11.83% | 0.37% | 11.16% |
| Earnings before Tax (EBT) 1 | 51.3 | 10.51 | -35.24 | 6.871 | -60.03 | 19.91 |
| Net income 1 | 38.74 | 6.552 | -37.88 | 0.531 | -55.34 | 20.3 |
| Net margin | 6.5% | 1.03% | -6.61% | 0.07% | -7.09% | 2.95% |
| EPS 2 | 2.306 | 0.3800 | -1.621 | 0.0200 | -2.320 | 0.8100 |
| Free Cash Flow 1 | -105.6 | 28.43 | -343.5 | -39.86 | -132.7 | -7.139 |
| FCF margin | -17.72% | 4.48% | -59.91% | -5.39% | -17% | -1.04% |
| FCF Conversion (EBITDA) | - | 30.99% | - | - | - | - |
| FCF Conversion (Net income) | - | 433.9% | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 19-03-02 | 19-10-04 | 20-09-06 | 21-09-06 | 22-09-05 | 23-09-05 |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 498 | 464 | 666 | 684 | 617 | 595 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 4.077 x | 5.055 x | 8.864 x | 5.608 x | 13.52 x | 4.542 x |
| Free Cash Flow 1 | -106 | 28.4 | -343 | -39.9 | -133 | -7.14 |
| ROE (net income / shareholders' equity) | 25.4% | 3.32% | -9.48% | 0.09% | -9.73% | 3.59% |
| ROA (Net income/ Total Assets) | 9.6% | 5.42% | 1.62% | 3.48% | 0.11% | 2.94% |
| Assets 1 | 403.4 | 120.9 | -2,332 | 15.24 | -49,495 | 691.3 |
| Book Value Per Share 2 | 10.20 | 12.70 | 24.90 | 24.90 | 22.20 | 23.00 |
| Cash Flow per Share 2 | 0.3500 | 1.360 | 1.910 | 1.000 | 0.5400 | 0.5300 |
| Capex 1 | 29.3 | 59.3 | 196 | 14.7 | 173 | 13.2 |
| Capex / Sales | 4.91% | 9.35% | 34.2% | 1.99% | 22.18% | 1.93% |
| Announcement Date | 19-03-02 | 19-10-04 | 20-09-06 | 21-09-06 | 22-09-05 | 23-09-05 |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +43.53% | 7.35M | |
| +55.32% | 815B | |
| +44.05% | 641B | |
| -6.75% | 352B | |
| +13.56% | 314B | |
| +10.68% | 303B | |
| +16.57% | 242B | |
| +2.04% | 224B | |
| +13.31% | 218B | |
| +8.48% | 168B |
- Stock Market
- Equities
- CHCL Stock
- Financials Cian Healthcare Limited
